Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 3 of 3

Publication Record


Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli from the milk of cows with clinical mastitis in Southern Taiwan.
Su Y, Yu CY, Tsai Y, Wang SH, Lee C, Chu C
(2016) J Microbiol Immunol Infect 49: 892-901
MeSH Terms: Animals, Anti-Bacterial Agents, Bacterial Proteins, Cattle, Cloxacillin, Electrophoresis, Gel, Pulsed-Field, Escherichia coli, Escherichia coli Infections, Escherichia coli Proteins, Female, Fluoroquinolones, Mastitis, Bovine, Microbial Sensitivity Tests, Milk, Multiplex Polymerase Chain Reaction, Taiwan, beta-Lactam Resistance, beta-Lactamases
Show Abstract · Added January 20, 2015
BACKGROUND/PURPOSE - Escherichia coli is a common pathogen to cause clinical and subclinical mastitis in cows. A total of 57 E. coli isolates from raw milk from cows were characterized genetically and biochemically.
METHODS - Extended-spectrum β-lactamase (ESBL) genes, the mechanism for fluoroquinolone resistance, and variations in virulence genes and genomes of these E. coli isolates were investigated by the antimicrobial susceptibility test, simplex and multiplex polymerase chain reaction (PCR), and pulsed-field gel electrophoresis (PFGE).
RESULTS - All E. coli isolates were resistant to cloxacillin (100%) and to a lesser extent (50%) to tetracycline, neomycin, gentamycin, ampicillin, ceftriaxone, cefotaxime (CTX), and ceftazidime (CAZ). Nearly 70% of the isolates were resistant to at least two antimicrobials and 28.1% carried AmpA and AmpC genes simultaneously. The predominant bla gene was bla, followed by bla, bla, bla, and bla Among the six (10.5%) ESBL-producing E. coli carrying bla, bla, or bla, two isolates 31 of ST410 in the ST23 complex and 58 of ST167 in the ST10 complex were also resistant to ciprofloxacin, enrofloxacin, and levofloxacin, with mutations at codon 83 from serine to leucine and codon 87 from aspartic acid to asparagine in GyrA and at codon 80 from serine to isoleucine in ParC. These isolates were genetically diverse in pulsotype analysis, lacked toxin genes of human pathogenic E. coli and carried mostly the prevalent virulence genes fimH, papGII, and α-hemolysin.
CONCLUSION - Lacking virulence genes examined, genetic diverse E. coli isolates are unrelated to human pathogenic E. coli. Enhancing sanitation in milk processing and transportation is needed to eliminate multidrug-resistant (MDR), fluoroquinolone-resistant, and ESBL-producing E. coli isolates.
Copyright © 2014. Published by Elsevier B.V.
0 Communities
1 Members
0 Resources
18 MeSH Terms
Vancomycin prescribing practices in hospitalized chronic hemodialysis patients.
Green K, Schulman G, Haas DW, Schaffner W, D'Agata EM
(2000) Am J Kidney Dis 35: 64-8
MeSH Terms: Adult, Aged, Cohort Studies, Cross Infection, Drug Prescriptions, Drug Utilization, Enterococcus, Female, Hemodialysis Units, Hospital, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Prospective Studies, Renal Dialysis, Staphylococcus aureus, Vancomycin, beta-Lactam Resistance
Show Abstract · Added March 13, 2015
To determine the prevalence of and indications for vancomycin administration among hospitalized chronic hemodialysis patients, we performed a 3-month prospective cohort study at a tertiary care center. Modified guidelines for vancomycin use from the Hospital Infections Control Practices Advisory Committee of the Centers for Disease Control and Prevention were used. Vancomycin was administered during 56 of 144 admissions (39%) requiring chronic hemodialysis compared with 336 of 7,212 admissions (5%) not requiring hemodialysis (relative risk, 11; 95% confidence interval, 8 to 15; P < 0.001). Among chronic hemodialysis patients, vancomycin use was judged appropriate for 131 of the 164 vancomycin doses (80%). The most common appropriate indication was empiric therapy in a febrile patient before culture or susceptibility results. Of 32 infections identified in patients who received empiric vancomycin, 15 infections (47%) were caused by beta-lactam-resistant pathogens. Among the 33 doses (20%) judged inappropriate, continued therapy for a presumed infection despite failure to identify a beta-lactam-resistant pathogen was the most common indication. Although vancomycin administration was frequent among hospitalized chronic hemodialysis patients, its use was justified in the majority of cases. Efforts should focus on limiting vancomycin administration for treating infections caused by beta-lactam-sensitive pathogens.
0 Communities
1 Members
0 Resources
18 MeSH Terms
Biochemical characterization of penicillin-resistant and -sensitive penicillin-binding protein 2x transpeptidase activities of Streptococcus pneumoniae and mechanistic implications in bacterial resistance to beta-lactam antibiotics.
Zhao G, Yeh WK, Carnahan RH, Flokowitsch J, Meier TI, Alborn WE, Becker GW, Jaskunas SR
(1997) J Bacteriol 179: 4901-8
MeSH Terms: Anti-Bacterial Agents, Carrier Proteins, Hydrolysis, Molecular Sequence Data, Penicillin-Binding Proteins, Penicillins, Peptidyl Transferases, Streptococcus pneumoniae, beta-Lactam Resistance, beta-Lactams
Show Abstract · Added December 12, 2013
To understand the biochemical basis of resistance of bacteria to beta-lactam antibiotics, we purified a penicillin-resistant penicillin-binding protein 2x (R-PBP2x) and a penicillin-sensitive PBP2x (S-PBP2x) enzyme of Streptococcus pneumoniae and characterized their transpeptidase activities, using a thioester analog of stem peptides as a substrate. A comparison of the k(cat)/Km values for the two purified enzymes (3,400 M(-1) s(-1) for S-PBP2x and 11.2 M(-1) s(-1) for R-PBP2x) suggests that they are significantly different kinetically. Implications of this finding are discussed. We also found that the two purified enzymes did not possess a detectable level of beta-lactam hydrolytic activity. Finally, we show that the expression levels of both PBP2x enzymes were similar during different growth phases.
0 Communities
1 Members
0 Resources
10 MeSH Terms